Omega Diagnostics Group PLC Statement re. Government press release

TIDMODX

Omega Diagnostics Group PLC

15 March 2021

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Statement re. Government press release

Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the press release issued this afternoon by the UK Government announcing its partnership with British rapid test manufacturers.

Further to the RNS announcement released by Omega this morning at 7am, the Company is named as one of two British companies to have secured contracts with the Government to supply rapid lateral flow tests.

Quote in the press release Colin King, CEO of Omega Diagnostics Group plc, said:

"We are delighted to deploy our state-of-the-art lateral flow test production facilities in support of the UK government's COVID-19 testing programme. The collaboration with other UK-based IVD companies and DHSC has facilitated the rapid development and manufacturing capability within the UK. We particularly welcome the government's assistance to secure the specialist machinery needed to dramatically increase the scale of our manufacturing capacity which has allowed us to ensure a ready supply of high quality, reliable British made rapid lateral flow tests.

"Rapid lateral flow tests are an essential tool for identifying COVID-19 cases where people have no visible symptoms but could still be infectious and continue to spread the virus. We are very proud to be playing our part in the nation's effort to control the spread of coronavirus by using our production facilities in Scotland."

The full text of the press release can be seen here:

https://www.gov.uk/government/news/uk-government-announces-partnership-with-british-rapid-test-manufacturers

The following press release was also released in Scotland:

https://www.gov.uk/government/news/uk-government-to-partner-with-clackmannanshire-test-manufacturer

Contacts:

 
  Omega Diagnostics Group PLC                              www.omegadiagnostics.com 
  Colin King, Chief Executive                                       via Walbrook PR 
  Kieron Harbinson, Group Finance 
   Director 
 
  finnCap Ltd                                                    Tel: [phone] 
  Geoff Nash/Edward Whiley (Corporate 
   Finance) 
  Alice Lane (ECM) 
 
  Walbrook PR Limited                    Tel: [phone] or [e-mail] 
  Paul McManus                                                   Mob: [phone] 
  Lianne Cawthorne                                               Mob: [phone] 
 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAGPUQPWUPGGMA

(END) Dow Jones Newswires

March 15, 2021 13:28 ET (17:28 GMT)